Normal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa

Rascol, O; Sabatini, U; Chollet, F; Fabre, N; Senard, J M; Montastruc, J L; Celsis, P; Marc-Vergnes, J P; Rascol, A
May 1994
Journal of Neurology, Neurosurgery & Psychiatry;May1994, Vol. 57 Issue 5, p567
Academic Journal
journal article
No abstract available.


Related Articles

  • Dampening of Serotonergic System through 5HT1A Receptors is a Promising Target for Treatment of Levodopa Induced Motor Problems. Mahmoudi, Javad; Farhoudi, Mehdi; Reyhani-Rad, Siamak; Sadigh-Eteghad, Saeed // Advanced Pharmaceutical Bulletin;Jun2013, Vol. 3 Issue 2, p439 

    During long-term treatment with Levodopa, majority of patients with Parkinson's disease experience some abnormal motor problems including of Levodopa induced dyskinesia (LID) and wearing off. Incredible evidences suggest that serotonergic neurons compensate some functions of lost dopaminergic...

  • Clinical Features, Pathophysiology, and Treatment of Levodopa-Induced Dyskinesias in Parkinson's Disease. Guridi, J.; González-Redondo, R.; Obeso, J. A. // Parkinson's Disease (20420080);2012, p1 

    Dyskinetic disorders are characterized by excess of motor activity that may interfere with normal movement control. In patients with Parkinson's disease, the chronic levodopa treatment induces dyskinetic movements known as levodopa-induced dyskinesias (LID). This paper analyzed the...

  • Rhythm-specific modulation of the sensorimotor network in drug-naïve patients with Parkinson’s disease by levodopa. Esposito, Fabrizio; Tessitore, Alessandro; Giordano, Alfonso; De Micco, Rosita; Paccone, Antonella; Conforti, Renta; Pignataro, Giuseppe; Annunziato, Lucio; Tedeschi, Gioacchino // Brain: A Journal of Neurology;Mar2013, Vol. 136 Issue 3, p710 

    Brain activity during rest is characterized by slow (0.01–0.1 Hz) fluctuations of blood oxygenation level-dependent functional magnetic resonance imaging signals. These fluctuations are organized as functional connectivity networks called resting-state networks, anatomically corresponding...

  • Disease progression, drug action and Parkinson’s disease: Why time cannot be ignored. Holford, Nick; Nutt, John G. // European Journal of Clinical Pharmacology;Feb2008, Vol. 64 Issue 2, p207 

    The article focuses on a study on progression of Parkinson’s disease (PD) and action of levodopa on the disease. Levodopa has been the mainstay of treatment of PD. Clinicians focused on the immediate response to levodopa by measuring in minutes to hours and trying to understand the...

  • Abnormal bidirectional plasticity-like effects in Parkinson’s disease. Huang, Ying-Zu; Rothwell, John C.; Lu, Chin-Song; Chuang, Wen-Li; Chen, Rou-Shayn // Brain: A Journal of Neurology;Aug2011, Vol. 134 Issue 8, p2312 

    Levodopa-induced dyskinesia is a major complication of long-term dopamine replacement therapy for Parkinson’s disease that becomes increasingly problematic in advanced Parkinson’s disease. Although the cause of levodopa-induced dyskinesias is still unclear, recent work in animal...

  • Treatment of Parkinsonism with Levodopa. Lee, John E.; Sweet, Richard D.; McDowell, Fletcher H. // Annals of Internal Medicine;Nov71, Vol. 75 Issue 5, p703 

    Describes the status of patients with Parkinson's disease at the end of 2 years of treatment with levodopa. Common side effects of levodopa; Clinical benefit of levodopa treatment for patients with Parkinson's disease; Recommended dosage of levodopa for the treatment of Parkinsonism.

  • Ropinirole: A Review of its Use in the Management of Parkinson's Disease. Matheson, A.J.; Spencer, C.M. // Drugs;Jul2000, Vol. 60 Issue 1, p115 

    Ropinirole, a non-ergoline dopamine agonist, has selective affinity for dopamine D-like receptors and little or no affinity for non-dopaminergic brain receptors. Ropinirole is indicated as adjunct therapy to levodopa in patients with advanced Parkinson's disease. It is also indicated, and recent...

  • Thalamic, pallidal, or subthalamic surgery for Parkinson’s disease? Krack, P.; Poepping, M.; Weinert, D.; Schrader, B.; Deuschl, G. // Journal of Neurology;Apr2000 Supplement 2, Vol. 247, p122 

    Levodopa is a highly effective treatment of all motor symptoms of Parkinson’s disease. However, long-term treatment with levodopa can lead to motor fluctuations and levodopa-induced dyskinesias. Motor side effects can become so disabling as to warrant surgical treatment. Both ablative...

  • A number of levodopa-based strategies may improve the management of motor complications in Parkinson's disease.  // Drugs & Therapy Perspectives;Nov2010, Vol. 26 Issue 11, p10 

    Levodopa is the most effective treatment for the signs and symptoms of Parkinson's disease. However, after a few years of levodopa treatment, the majority of patients will experience motor fluctuations and dyskinesia. A variety of levodopa- based strategies are available that aim to stabilize...

  • TIPS for Patients With Parkinson's Disease.  // Neurology Reviews;Aug2011, Vol. 19 Issue 8, p16 

    The article presents effective tips and suggestions for patients with idiopathic Parkinson's disease regarding disease management and treatment. It indicates that walking is an essential adjunctive therapy for patients with Parkinson's disease. It suggests that sipping liquid carbidopa-levodopa...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics